Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Romeo

Showing results (221-230 of 248) with videos related to

Pageof 25
Sort By:
Frontiers in Medicine|August 15, 2020
Long-Term Clinical, Audiological, Visual, Neurocognitive and Behavioral Outcome in Children With Symptomatic and Asymptomatic Congenital Cytomegalovirus Infection Treated With ValganciclovirArianna Turriziani Colonna, Danilo Buonsenso, Davide Pata, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 31, 2019
Assessment of neurocognitive decline in cancer patients, except brain cancer, under long-term treatment with bevacizumabC Panciroli, G Lucente, L Vidal, et al.
Early Human Development|July 21, 2020
Early visual and neuro-development in preterm infants with and without retinopathyDaniela Ricci, Simona Lucibello, Lorenzo Orazi, et al.
European Journal of Histochemistry : EJH|February 3, 2012
Hsp10, Hsp70, and Hsp90 immunohistochemical levels change in ulcerative colitis after therapyG Tomasello, C Sciumé, F Rappa, et al.
Pediatrics|December 3, 2008
Visual function at 35 and 40 weeks' postmenstrual age in low-risk preterm infantsDaniela Ricci, Laura Cesarini, Domenico M M Romeo, et al.
ESMO Open|December 17, 2021
Maintenance therapy of patients with recurrent epithelial ovarian carcinoma with the anti-tumor-associated-mucin-1 antibody gatipotuzumab: results from a double-blind, placebo-controlled, randomized, phase II studyJ A Ledermann, B Zurawski, F Raspagliesi, et al.
Plos One|August 6, 2016
Revised North Star Ambulatory Assessment for Young Boys with Duchenne Muscular DystrophyEugenio Mercuri, Giorgia Coratti, Sonia Messina, et al.
Gynecologic Oncology|December 16, 2018
Chemotherapy and PARP inhibitors in heavily pretreated BRCA1/2 mutation ovarian cancer (BMOC) patientsV Rodriguez-Freixinos, L Fariñas-Madrid, M Gil-Martin, et al.
Sleep Medicine|February 21, 2017
Sleep disorders in spinal muscular atrophyMaria C Pera, Domenico M Romeo, Alessandra Graziano, et al.
Early Human Development|January 18, 2011
Early visual assessment in preterm infants with and without brain lesions: correlation with visual and neurodevelopmental outcome at 12 monthsDaniela Ricci, Domenico M Romeo, Francesca Gallini, et al.
Pageof 25

Showing results (221-230 of 248) with videos related to

Sort By:
Pageof 25
Frontiers in Medicine|August 15, 2020
Long-Term Clinical, Audiological, Visual, Neurocognitive and Behavioral Outcome in Children With Symptomatic and Asymptomatic Congenital Cytomegalovirus Infection Treated With ValganciclovirArianna Turriziani Colonna, Danilo Buonsenso, Davide Pata, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 31, 2019
Assessment of neurocognitive decline in cancer patients, except brain cancer, under long-term treatment with bevacizumabC Panciroli, G Lucente, L Vidal, et al.
Early Human Development|July 21, 2020
Early visual and neuro-development in preterm infants with and without retinopathyDaniela Ricci, Simona Lucibello, Lorenzo Orazi, et al.
European Journal of Histochemistry : EJH|February 3, 2012
Hsp10, Hsp70, and Hsp90 immunohistochemical levels change in ulcerative colitis after therapyG Tomasello, C Sciumé, F Rappa, et al.
Pediatrics|December 3, 2008
Visual function at 35 and 40 weeks' postmenstrual age in low-risk preterm infantsDaniela Ricci, Laura Cesarini, Domenico M M Romeo, et al.
ESMO Open|December 17, 2021
Maintenance therapy of patients with recurrent epithelial ovarian carcinoma with the anti-tumor-associated-mucin-1 antibody gatipotuzumab: results from a double-blind, placebo-controlled, randomized, phase II studyJ A Ledermann, B Zurawski, F Raspagliesi, et al.
Plos One|August 6, 2016
Revised North Star Ambulatory Assessment for Young Boys with Duchenne Muscular DystrophyEugenio Mercuri, Giorgia Coratti, Sonia Messina, et al.
Gynecologic Oncology|December 16, 2018
Chemotherapy and PARP inhibitors in heavily pretreated BRCA1/2 mutation ovarian cancer (BMOC) patientsV Rodriguez-Freixinos, L Fariñas-Madrid, M Gil-Martin, et al.
Sleep Medicine|February 21, 2017
Sleep disorders in spinal muscular atrophyMaria C Pera, Domenico M Romeo, Alessandra Graziano, et al.
Early Human Development|January 18, 2011
Early visual assessment in preterm infants with and without brain lesions: correlation with visual and neurodevelopmental outcome at 12 monthsDaniela Ricci, Domenico M Romeo, Francesca Gallini, et al.
Pageof 25